New artificial pancreas uses two hormones instead of one
The JDRF Artificial Pancreas Consortium has made significant advancements in their quest to develop a safe and effective automated diabetes management system, with trials already showing it is possible to maintain healthy blood glucose levels in people with type 1 diabetes without the need for human intervention.
To date, the closed-loop systems tested have combined an insulin pump with glucose monitoring and complex computer programs designed to predict and activate insulin release as required. Whilst results of these trials have been overwhelmingly positive, researchers have found it to be more difficult than first anticipated to finely tune blood glucose levels – particularly when protecting patients against potentially dangerous hypoglycemia caused by too much insulin.
10 Comments 
JDRF is proud to award the 2009 Freedom Award to joint recipients for the first time in the history of this prestigious award. These recipients are Boral Limited and Macquarie Group. The JDRF Freedom Award recognises the highest corporate fundraising organisation over a calendar year and represents a deep and significant partnership between these organisations and JDRF.
JDRF researchers from Canada show that a new vaccine can cure type 1 diabetes in mice and slow the onset of the condition in mice at risk of the disease.
JDRF researchers have shown for the first time that other pancreas cells can spontaneously re-program themselves to produce insulin without the need for complex genetic modification or surgical transplantation.
